Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Pharma stocks reacted sharply to concerns that the US might impose tariffs on pharmaceutical imports, causing the Nifty ...

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...

Today, majors across segments including Parle Industries, Easy Trip Planners, Bajaj Consumer Care, Aditya Birla Fashion & ...

The Nifty Pharma Index has taken a hit, dropping nearly 2% in Friday’s trade. Over the last five days, the index has declined by approximately 4.3%, and on a year-to-date basis, it has fallen by ...

Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

The Trump Tariff Shock Hits India Hard 📉 The Indian stock market is experiencing one of its most painful phases, battered by ...

Indian stock markets on Friday continued their downward trend for the eighth straight session, with both the Sensex and the Nifty ended in the negative territory amid global trade uncertainties.